Abstract
“Milky” blood was observed frequently by physicians of the last century when blood letting was liberally employed. The fact that this turbid to creamy appearance of the blood serum was usually attributable to a high fat content had been clearly demonstrated by Hewson in 1774. However, numerous reports of serum turbidity prior to 1850 probably included conditions other than hyperlipemia (leukemias, etc.).
Work performed during tenure of a research fellowship at the Institute for Metabolic Research, Highland General Hospital, Oakland, Cal.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abegg, W.: Ein Fall von hochgradiger alimentärer “hepatogener” Fettretention im Blut bei einem 11jährigen Kinde. Jb. Kinderheilk. 149, 94 (1937).
Addison, T., and W. Gull: On a certain affection of the skin, vitiligoidea (a) plana, (b) tuberosa with remarks. Guy’s Hosp. Rep. 7, 265 (1850).
Adlersberg, D.: Inborn errors of lipid metabolism. Clinical, genetic, and chemical aspects. Arch. Path. 60, 48 (1955).
Adlersberg, D. and C. Wang: Syndrome of idiopathic hyperlipemia, mild diabetes mellitus and severe vascular damage. Diabetes 4, 210 (1955).
Ahrensjr., E. H.: Essential Hyperlipemia, in: “Fat metabolism”, p. 61. Baltimore: Johns Hopkins Press 1954.
Ahrensjr., E. H.: Nutritional factors and serum lipid levels. Amer. J. Med. 23, 928 (1957).
Ahrensjr., E. H.: Symposium on pathophysiological and clinical aspects of lipid metabolism. Heidelberg 1965. G. Schettler (ed.). Stuttgart: Thieme 1966.
Ahrensjr., E. H., J. Hirsch, W. Insulljr., T. T. Tsaltas, R. Blomstrand, and M. L. Peterson: The influence of dietary fats on serum-lipid levels in man. Lancet 1957/I, 943.
Ahrensjr., E. H., J. Hirsch, K. Oette, J. W. Farquhar, and Y. Stein: Carbohydrate-induced and fat-induced lipemia. Trans. Ass. Amer. Phycns. 74, 134 (1961).
Ahrensjr., E. H. and N. Spritz: Further studies on fat- and carbohydrate-induced lipemia in man. Reduction of lipemia by feeding fat; in: Biochemical problems of lipids, A. C. Frazer (ed.), p. 304. Amsterdam: Elsevier Pubi. Co. 1963.
Albrink, M. J.: Lipoprotein pattern as a function of total triglyceride concentration of serum. J. clin. Invest. 40, 536 (1961).
Albrink, M. J.: Triglycerides, lipoproteins and coronary artery disease. Arch, intern. Med. 109, 345 (1962).
Albrink, M. J., J. R. Fitzgerald, and E. B. Man: Reduction of alimentary lipemia by glucose. Metabolism 7, 162 (1958).
Albrink, M. J. and E. B. Man: Serum triglycerides in coronary artery disease. Arch, intern. Med. 103, 4 (1959).
Albrink, M. J. and E. B. Man, and J. P. Peters: The relation of neutral fat to lactescence of serum. J. clin. Invest. 34, 147 (1955).
Albrink, M. J., J. W. Meigs, and M. A. Granoff: Weight gain and serum triglycerides in normal men. New Engl. J. Med. 266, 484 (1965).
Albrink, M. J., J. W. Meigsand E. B. Man: Serum lipids, hypertension and coronary artery disease. Amer. J. Med. 31, 4 (1961).
Alvarez, R. R., D. F. Gaiser, D.M. Simkins, E. K. Smith, and G. E. Bratvold: Serial studies of serum lipids in normal human pregnancy. Amer. J. Obstet. Gynec. 77, 743 (1959).
Angervall, G., P. Björntorp, and B. Hood: Studies on the clearing phenomenon in essential hyperlipemia. Acta med. scand. 172, 5 (1962).
Berkowitz, D., and S. Glassman: Gout, hyperlipidemia, and diabetes inter-relationships. Clin. Res. 13, 318 (1965).
Berkowitz, D., J. J. Spitzer, and W. Likoff: Practical significance of serum triglycerides and radioactive fat tolerance. Their relation to current therapy for hypercholesterolemia. Amer. J. Cardiol. 10, 198 (1962).
Bernhard, E.: Über einen Fall von Lipämie. Schweiz, med. Wschr. 66, 261 (1936).
Bernstein, S. S., H. H. Williams, F. C. Hummel, M. L. Shepherd, and B. N. Erickson: Metabolie observations on a child with essential hyperlipemia. J. Pediat. 14, 570 (1939).
Best, M. M., and C. H. Duncan: Hypoglyceridemic effect of ethyl-alpha-p-chlorophenoxyisobutyrate with and without androsterone. Circulation 28, 690 (1963).
Best, M. M., and C. H. Duncan: Effects of cholesterol-lowering drugs on serum triglycerides. J. Amer. med. Ass. 187, 37 (1964).
Betzing, H.: Personal communication (1965).
Beumer, H., und M. Bürger: Beiträge zur Chemie des Blutes in Krankheiten mit besonderer Berücksichtigung der Lipoide. IV. Mitteilung: Diabetes und Lipämie. Z. exp. Path. Ther. 13, 362 (1913).
Bezman, A., J. M. Felts, and R. J. Havel: Relationship between incorporation of triglyceride fatty acids and heparin-released lipoprotein lipase from adipose tissue slices. J. Lipid Res. 3, 427 (1962).
Bialkin, G., S. Zucker, B. S. Sklarin, K. Hirschhorn, and M. Davidson: A genetic and metabolic study of a family with hyperlipemia. Pediatrics 29, 566 (1962).
Bierman, E. L.: Particulate lipid components in plasma. In: Handbook of Physiology. Section 5: Adipose tissue. A. E. Renold and G. F. Cahill jr. (ed.), p. 511. Baltimore: Williams and Wilkins 1965.
Bierman, E. L., E. Gordis, and J. T. HamlinIII: Heterogeneity of fat particles in plasma during alimentary lipemia. J. clin. Invest. 41, 2254 (1962).
Bierman, E. L. and J. T. Hamlin: The hyperlipemic effect of a low fat, high carbohydrate diet in diabetic subjects. Diabetes 10, 432 (1961).
Bloomfield, A. L., and B. Shenson: The syndrome of idiopathic hyperlipemia with crises of violent abdominal pain. Stanf. med. Bull. 5, 185 (1947).
Bloom, B., I. L. Chaikoff, and W. O. Reinhardt: Intestinal lymph as pathway of transport of absorbed fatty acids of different chain length. Amer. J. Physiol. 166,451 (1951).
Bierman, E. L., D. Portejr., D. D. O’Hara, M. Schwartz, and F. C. Woodjr.: Characterization of fat particles in plasma of hyperlipemic subjects maintained on fat-free, highcarbohydrate diets. J. clin. Invest. 44, 261 (1965).
Binet, L., et P. Brocq: La lactescence du sérum sanguin au cours de la pancréatite hémorrhagique. Paris med. 71, 489 (1929).
Boggs, J. D., D. Y. Y. Hsia, R. F. Mais, and J. A. Bigler: The genetic mechanism of idiopathic hyperlipemia. New Engl. J. Med. 257, 1101 (1957).
Boggs, T., and R. Morris: Experimental lipemia in rabbits J. exp. Med. 11, 553 (1909).
Bohman, A. M.: Hyperlipemi av okaend genes. (2 fall). Nord. Med. 46, 1076 (1951).
Borrie, P.: Essential hyperlipemia and idiopathic hypercholesterolemic xanthomatosis. Brit. med. J. 1957/II, 911.
Borrie, P.: The treatment of xanthomatosis with Atromid. Brit. J. Derm. 76, 53 (1964).
Borrie, P.: Treatment of xanthomatosis. Brit. med. J. 1964/II, 1135.
Bragdon, J. H., and R. S. Gordon: Tissue distribution of C-14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat. J. clin. Invest. 37, 574 (1958).
Bragdon, J. H. and R. J. Havel: In vivo effect of anti-heparin agents on serum lipids and lipoproteins. Amer. J. Physiol. 177, 128 (1954).
Bragdon, J. H. and E. Boyle: Human serum lipoproteins. I. Chemical composition of four fractions. J. Lab. clin. Med. 48, 36 (1956).
Bragdon, J. H. and A. Karmen: The fatty acid composition of chylomicrons of chyle and serum following the ingestion of different oils. J. Lipid. Res. 1, 167 (1960).
Brehmer, W., u. P. Lubbers: Über eine generalisierte Xanthomatose mit Knochenbefall und diffuser Plasmazeil Wucherung im Knochenmark bei essentieller Hyperlipämie. Vir-chows Arch. Path. Anat. 318, 394 (1950).
Brown, D. F., A. S. Heslin, and J. T. Doyle: Postprandial lipemia in health and in ischemic heart diesase. New Engl. J. Med. 264, 733 (1961).
Brunner, W.: Beitrag zur pankreatogenen Lipämie. Klin. Wschr. 14, 1853 (1935).
Bruton, O. C., and A. J. Kanter: Idiopathic familial hyperlipemia Amer. J. Dis. Child. 82, 153 (1951).
Bürger, M., u. O. Grütz: Über hepatosplenomegale Lipidose mit Xanthomatosen Veränderungen in Haut und Schleimhaut. Arch. Derm. Syph. (Beri.) 166, 542 (1932).
Camelin, A., P. Accoyer, L. Dutel, et G. Gatjron: Hyperlipémie essentielle de l’adulte. Incidences et accidents thérapeutiques. Bull. Mém. Soc. Med. Hop. Paris 4, 1116 (1955).
Carlson, L. A., and B. Olhagen: The electrophoretic mobility of chylomicrons in a case of essential hyperlipemia. Scand. J. clin. Lab. Invest. 6, 70 (1954).
Carlson, L. A., and B. Olhagen: Studies on a case of essential hyperlipemia. Blood lipids, with special reference to the composition and metabolism of the serum triglycerides before, during and after the course of a viral hepatitis. J. clin. Invest. 38, 854 (1959).
Carlson, L. A., B. Högstedt, and L. Örö: Effect of Atromid on plasma lipids and lipoproteins in subjects with hyperlipoproteinemia. J. Atheroscler. Bes. 3, 467 (1963).
Carson, P., L. McDonald, S. Pickard, T. Pilkington, B. Davies, and F. Love: Effect of Atromid on platelet stickiness. J. Atheroscler. Res. 3, 619 (1963).
Carteaud, A., et H. Mamotj: Sur deux cas de xanthomatoses. Hyperlipémie essentielle et Xanthomatose familiale. Action de l’heparine locale. Sem. Hop. (Paris) 26, 1501 (1956).
Cetnarowicz, H., M. Kopec, J. Zajaczkowski, and E. Kowalski: Samoistne Zwiekszenie sie zawartosci tluszczu we Krwi (hyperlipaemia essentialis). Pol. Tyg. lek. 8, 713 (1953).
Chapman, F. D., and T. D. Kinney: Hyperlipemia, “idiopathic hyperlipemia”. Amer. J. Dis. Child. 62, 1014 (1941).
Christensen, S., E. Dollertjp, and S. E. Jensen: Idiopathic hyperlipemia, latent diabetes mellitus, and severe neuropathy. Acta med. scand. 161, 57 (1958).
Collett, R. W., and R. L. J. Kennedy: Chronic relapsing pancreatitis associated with hyperlipemia in an eight year old boy. Proc. Mayo Clin. 23, 158 (1948).
Condon, R. E., H. Tobias, and D. V. Datta: The liver and postheparin plasma lipolytic activity in dog and man. J. clin. Invest. 44, 860 (1965).
Cornbleet, T.: Local action of heparin on xanthomas. Arch. Derm. 71, 172 (1955).
Cornwell, D. G., F. A. Krtjger, G. J. Hamwi, and J. B. Brown: Studies on the characterization of human serum lipoproteins separated by ultracentrifugation in a density gradient. II. Serum lipoproteins in hyperlipemic subjects. Amer. J. clin. Nutr. 9, 41 (1961).
Cotton, R. C, E. G. Wade, and G. W. Spiller: The effect of Atromid on plasma fibrinogen and heparin resistance. J. Atheroscler. Res. 3, 648 (1963).
Cottnihan, T. B., and P. Keelan: Atromid in high cholesterol states. J. Atheroscler. Res. 3, 580 (1963).
Cramer, K.: Action of Atromid on serum lipids and on beta-lipoprotein lipids and protein. J. Atheroscler. Res. 3, 500 (1963).
Crocker, A. C: Skin xanthomas in childhood. Pediatrics 8, 573 (1951).
Crofford, O. B.: Studies on the mechanism of idiopathic hyperlipemia with hyperglycemia. Metabolism 11, 1194 (1962).
Davidson, P., and M. J. Albrink: Hypertriglyceridemia and impaired glucose tolerance. Clin. Res. 11, 216 (1963).
Delcotjrt, R., and H. Vastesaeger: Action of Atromid on total and beta-cholesterol. J. Atheroscler. Res. 3, 533 (1963).
DeRosa, L.: Su di un caso di infiltrazione lipoidea della retina. Boll. Oculist. 31, 677 (1952).
Dietrich, F.: Zur Differenzierung der Lipoproteide des Serums mittels präparativer Elektrophoresemethoden. Hoppe-Seylers Z. physiol. Chem. 302, 227 (1955).
Dole, V. P.: A relationship between non-esterified fatty acids in plasma and the metabolism of glucose. J. clin. Invest. 35, 150 (1956).
Dole, V. P., E. Gordis, and E. L. Bierman: Hyperlipemia and arteriosclerosis. New Engl. J.Med. 269, 686 (1963).
Dole, V. P., and J. T. HamlinIII: Particulate fat in lymph and blood. Physiol. Rev. 42, 674 (1962).
Duncan, C. H., and M. M. Best: Inhibition of hepatic secretion of triglycerides by chlorophenoxyisobutyrate. Circulation 30, suppl. III, 7 (1964).
Duncan, C. H., and M. M. Best: A comparison of the effects of ethyl chlorophenoxyisobutyrate and nicotinic acid on plasma free fatty acids. Lancet 1965/I, 191.
Dunphy, E. B.: Ocular conditions associated with idiopathic hyperlipemia. Amer. J. Ophthal. 33, 1579 (1950).
Eggstein, M.: Die essentielle Hyperlipämie. Klinik der Gegenwart 9, 637 (1960).
Eisalo, A., P. Ahrenberg, and E. A. Nikkilä: Treatment of hyperlipidemia with dextrothyroxine. Acta med. scand. 173, 639 (1963).
Engelberg, H.: Heparin lipemia clearing reaction and fat transport in man. Summary of available knowledge. Amer. J. clin. Nutr. 8, 21 (1960).
Engelberg, H.: Lipid metabolic studies in patients with essential hypertriglyceridemia. Metabolism 11, 1250 (1962).
Engelberg, H.: Effect of highly unsaturated fat upon the rate of lipolysis of fasting triglycerides by postheparin lipoprotein lipase. Circulation 30, suppl. III, 9 (1964).
Farquhar, J. W., R. C. Gross, R. M. Wagner, and G. M. Reaven: Validation of an incompletely coupled two-compartment nonrecycling catenary model for turnover of liver and plasma triglyceride in man. J. Lipid Res. 6, 119 (1965).
Farquhar, J. W., G. M. Reaven, R. C. Gross, and R. M. Wagner: Rate of plasma triglyceride synthesis in carbohydrate-induced lipemia. J. clin. Invest. 42, 930 (1963).
Farquhar, J. W., G. M. Reaven, R. M. Wagner, and R. C. Gross: Studies of hepatic and plasma triglyceride turnover in man. J. clin. Invest. 43, 1299 (1964).
Fasoli, A., and A. Cesana: Serum lipid and lipoprotein changes after treatment with Atromid in patients with atherosclerosis, essential hyperlipemia and familial hypercholesterolemia. J. Atheroscler. Res. 3, 475 (1963).
Feigl, J.: Über das Verhalten und die Verteilung von Fetten und Lipoiden im Blute nach Blutentziehung. Chemischer Beitrag zur Kenntnis des Lipämiegebietes VII. Biochem. Z. 115, 63 (1921).
Felber, J. P., et A. Vannotti: EfFet du taux des acides gras libres (NEFA) plasmatiques sur la glycémie et l’insulinémie. Helv. physiol. pharmacol. Acta 22, 13 (1964).
Felts, J. M.: The metabolism of chylomicron triglycerides by perfused rat livers and by intact rats. Ann. N.Y. Acad. Sci. 131, 24 (1965).
Field, R. A.: Glycogen deposition diseases, in: The Metabolic Basis of Inherited Disease, p. 178. Ed. Stanbury, Wyngaarden, Fredrickson. New York: McGraw-Hill Book Co. 1960.
Fischer, B.: Über Lipämie und Cholesterinämie sowie über Veränderungen des Pankreas und der Leber bei Diabetes mellitus. Virchows Arch. Path. Anat. 172,30 u. 218 (1903).
Fleischmajer, R.: The Dyslipidoses. Springfield (III.): Thomas 1960.
Fletcher, R. F., and J. Gloster: The lipids in xanthomata. J. clin. Invest. 43, 2104 (1964).
Frank, L., and L. M. Levitt: Idiopathic hyperlipemia with secondary xanthomatosis. Arch. Derm. Syph. (Chic.) 64, 434 (1951).
Franklin, S. N.: Splenomegaly with lipemia. Proc. roy. Soc. Med. 30, 711 (1937).
Fredrickson, D. S. in: The Metabolic Basis of Inherited Disease. Ed.: Stanbury, Wyngaarden, Fredrickson. New York: McGraw-Hill Book Co. 1960.
Fredrickson, D. S. Symposium on pathophysiological and clinical aspects of lipid metabolism, Heidelberg 1965. G. Schettler (ed.). Stuttgart: Thieme 1966.
Fredrickson, D. S. and R. S. Gordon: Transport of fatty acids. Physiol. Rev. 38, 585 (1958).
Fredrickson, D. S. and R. S. Lees: A system for phenotyping hyperlipoproteinemia. Circulation 31, 321 (1965).
Fredrickson, D. S. and R. S. Lees in: The Metabolic Basis of Inherited Disease. Ed.: Stanbury, Wyngaarden, Fredrickson. New York: McGraw-Hill Book Co. 1966.
Fredrickson, D. S., D. L. McCollesterand K. Ono: The role of unesterified fatty acid transport in chylomicron metabolism. J. clin. Invest. 37, 1333 (1958).
Fredrickson, D. S., K. Ono, and L. L. Davis: Lipolytic activity of post-heparin plasma in hyperglyceridemia. J. Lipid. Res. 4, 24 (1963).
Friedberg, S. J., and E. H. Estes, jr.: Tissue distribution and uptake of endogenous lipoprotein triglycerides in the rat. J. clin. Invest. 43, 129 (1964).
FromHansen, P.: The effect of diet, D-thyroxin and Atromid on serum cholesterol and triglycerides in man. J. Atheroscler. Res. 3, 584 (1963).
Fulton, J. K.: Essential lipemia, acute gout, peripheral neuritis, and myocardial disease in a Negro man. Arch, intern. Med. 89, 303 (1952).
Furman, R. H., R. P. Howard, and P. Alaupovic: Effect of chronic heparin administration on serum lipids, lipoproteins, nitrogen and electrolyte balance in normal and heparin-responsive and heparinunresponsive hyperglyceridemic subjects. Metabolism 11, 879 (1962).
Furman, R. H., R. P. Howard, O.J. Brusco, and P. Alaupovic: Effects of medium chain-length triglycerides in hyperchylomicronemia (dietary fat-induced hyperglyceridemia), a type of familial hyperlipemia. J. Lab. clin. Med. 62, 876 (1963).
Furman, R. H., R. P. Howard, K. Lakshmi, and L. N. Norcia: The serum lipids and lipoproteins in normal and hyperlipidemic subjects as determined by preparative ultracentrifugation. Effects of dietary and therapeutic measures. Changes induced by in vitro exposure of serum to sonic forces. Amer. J. clin. Nutr. 9, 73 (1961).
Furman, R. H. and C. W. Robinsonjr. in: “Adipose tissue as an organ”, p. 213—222. Ed.: L. W. Kinsell. Springfield (III.): Thomas 1962.
Furman, R. H. S. S. Sanbar, P. Alaupovic, R. H. Bradford, and R. P. Howard: Studies of the metabolism of radioiodinated human serum alpha-lipoprotein in normal and hyperlipemic subjects. J. Lab. clin. Med. 63, 193 (1964).
Gadrat, J.: L’hyperlipémie essentielle. Paris: Masson et Cie. 1958.
Gadrat, J., A. Bazex, A. Dupré, et R. Douste-Blazy: Xanthomes miliaires et très forte hyperlipidémie évoluant enpoussées déclenchées par une alimentation hyperlipidique. “Hyperlipémie essentielle de l’adulte avec eruption secondaire de xanthomes”. Bull. Soc. Frano. Derm. Syph. 59, 359 (1952).
Gage, S. H., and P. A. Fish: Fat digestion, absorption, and assimilation in man and animals as determined by the dark-field microscope, and a fat-soluble dye. Amer. J. Anat. 34, 1 (1924).
Garunas, A.: Abdominal pain in essential hyperlipemia. J. Amer. med. Ass. 163,1135 (1957).
Gaskins, A. L., R. B. Scott, and A. D. Kessler: Report of three cases of idiopathic familial hyperlipemia: Use of ACTH and cortisone. Pediatrics 11, 480 (1953).
Gilbert, J. B., and J. F. Mustard: Some effects of Atromid on plateled economy and blood coagulation in man. J. Atheroscler. Res. 3, 623 (1963).
Gofman, J., F. T. Lindgren, and H. Elliot: Ultracentrifugai studies of lipoproteins of human serum. J. biol. Chem. 179, 973 (1949).
Gofman, J., L. Rubin, J. P. McGinley, and H. B. Jones: Hyperlipoproteinemia. Amer. J. Med. 17, 514 (1954).
Goodman, M., H. Shuman, and S. Goodman: Idiopathic lipemia with secondary xanthomatosis, hepatosplenomegaly, and lipemia retinalis. J. Pediat. 16, 598 (1940).
Gordis, E.: Demonstration of two kinds of fat particles in alimentary lipemia with polyvinylpyrrolidone gradient columns. Proc. Soc. exp. Biol. (N. Y.) 110, 657 (1962).
Gould, R. G., D. R. Avoy, and E. A. Swyryd: Effect of alpha-parachlorophenoxyisobutyrate on cholesterol. Circulation 30, suppl. III, 11 (1964).
Gousios, A., J. M. Felts, and R. J. Havel: The metabolism of serum triglycerides and free fatty acids by the myocardium. Metabolism 12, 75 (1963).
Green, K. G., W. H. W. Inman, and J. M. Thorp: Multi-centre trial of a mixture of ethyl chlorophenoxyisobutyrate and androsterone (Atromid) in the United Kingdom and Ireland: A preliminary report. J. Atheroscler. Res. 3, 593 (1963).
Greig, H. B. W.: Inhibition of fibrinolysis by alimentary lipemia. Lancet 1956/II, 16.
Grossmann, E. E., and J. B. Hitz: Lipemia retinalis associated with essential hyperlipemia. Arch. Ophthal. 40, 570 (1948).
Grütz, O.: Zur Klinik und Histologie des Xanthoms bzw. der anisotropen Verfettung der Haut, nebst Bemerkungen über das Speicherungsvermögen der sog. Xanthomzellen. Arch. Derm. Syph. (Beri.) 150, 137 (1926).
Gustafson, A., P. Alaupovic, and R. H. Furman: Studies of the composition and structure of serum lipoproteins: Isolation, purification, and characterization of very low density lipoproteins of human serum. Biochemistry 4, 596 (1965).
Haensch, R.: Heparin-Therapie und Klinik der idiopathischen hyperlipidämischen Xanthomatose. Arch. klin. exp. Derm. 205, 512 (1958).
Hahn, P. F.: Abolishment of alimentary lipemia following injection of heparin. Science 98, 19 (1943).
Haklmi, P.: Hyperlipémie essentielle. These (Genève) 2287 (1954).
Hales, C. N., and P. J. Rändle: Effects of low-carbohydrate diet and diabetes mellitus on plasma concentrations of glucose, nonesterified fatty acid, and insulin during oral glucose-tolerance tests. Lancet 1963/I, 790.
Hamwi, G. J., O. Garcia, F. A. Kruger, G. Gwinup, and D. G. Cornwell: Hyperlipidemia in uncontrolled diabetes. Metabolism 11, 850 (1962).
Harlan, W. R., and D. E. Beischer: Changes in serum lipoproteins after a large fat meal in normal individuals and in patients with ischemic heart disease. Amer. Heart J. 66, 61 (1963).
Harrison, M. T., and D. M. Goldberg: The effect of Atromid in essential hyperlipemia. J. Atheroscler. Res. 3, 561 (1963).
Harslof, E.: Idiopathic familial hyperlipemia attended with hepatosplenomegaly. Acta med. scand. 130, 140 (1948).
Hatch, F. T., L. L. Abell, and F. E. Kendall: Effect of restriction of dietary fat and cholesterol upon serum lipids and lipoproteins in patients with hypertension. Amer. J. Med. 19, 48 (1955).
Havel, R. J.: Early effects of fasting and of carbohydrate ingestion on lipids and lipoproteins of serum in man. J. clin. Invest. 36, 855 (1957).
Havel, R. J.: Transport and metabolism of chylomicra. Amer. J. clin. Nutr. 6, 662 (1958).
Havel, R. J.: Conversion of plasma free fatty acids into triglycerides of plasma lipoprotein fractions in man. Metabolism 10, 1031 (1961).
Havel, R. J.: H. A. Eder, and J. H. Bragdon: The distribution and chemical composition of ultra-centrifugally separated lipoproteins in human serum. J. clin. Invest. 34, 1345 (1955).
Havel, R. J., J. M. Felts, and C. M. VanDuyne: Formation and fate of endogenous triglycerides in blood plasma of rabbits. J. Lipid Res. 3, 297 (1962).
Havel, R. J. and D. S. Fredrickson: The metabolism of chylomicra. I. The removal of palmitic acid-l-C14 labeled chylomicra from dog plasma. J. clin. Invest. 35, 1025 (1956).
Havel, R. J. and A. Goldfien: The role of the liver and of extrahepatic tissues in the transport and metabolism of fatty acids and triglycerides in the dog. J. Lipid. Res. 2, 389 (1961).
Havel, R. J. and R. S. Gordon: Idiopathic hyperlipemia: Metabolic studies in an affected family. J. clin. Invest. 39, 1777 (1960).
Hellems, H. K., and T. J. Regan: The influence of postprandial lipemia on myocardial blood flow and metabolism. Amer. Coll. Physiol. Proc. 41st Annual Session, April 1960 (cit. by Brown et. al. 1961).
Hellman, L., B. Zumoff, G. Kessler, E. Kara, I. L. Rubin, and R. S. Rosenfeld: Reduction of cholesterol and lipids in man by ethyl p-chlorophenoxyisobutyrate. Ann. intern. Med. 59, 477 (1963).
Herbst, F. S. M., W. F. Lever, and N. A. Hurley: Idiopathic hyperlipemic and primary hypercholesteremic xanthomatosis. VI. Studies of the serum proteins and lipoproteins by moving boundary electrophoresis and paper electrophoresis before and after administration of heparin. J. invest. Derm. 24, 507 (1955).
Hewson, W.: cit. from S. H. Gage, and P. A. Fish. Amer. J. Anat. 34, 1 (1924).
Heyl, A. G.: Intraocular lipemia. Trans. Amer. Ophth. Soc. 3, 54 (1880).
Hirschhorn, K., R. Hirschhorn, M. Fraccaro, and J. A. Book: Incidence of familial hyperlipemia. Science 129, 716 (1959).
Hoffman, L., and R. Grayson: Primary hyperlipemia. US armed Forces med. J. 3, 1667 (1952).
Hollister, L. E., and S. L. Kanter: Essential hyperlipemia treated with heparin and with chlorpromazine. Gastroenterology 29, 1069 (1955).
Holt, L. E., F. X. Aylward, and H. G. Timbres: Idiopathic familial lipemia. Bull. John Hopk.Hosp. 64,279(1939).
Hopgood, W. C: Idiopathic hyperlipemia. New Engl. J. Med. 238, 429 (1948).
Howard, R. P., P. Alaupovic, O. J. Brusco, and R. H. Furman: Effects of ethyl chloro-phenoxyisobutyrate, alone or with androsterone (Atromid), on serum lipids, lipoproteins and related metabolic parameters in normal and hyperlipidemic subjects. J. Atheroscler. Res. 3, 482 (1963).
Isselbacher, K. J.: in “Fat as a Tissue”, p. 7. Eds.: K. Rodahl, and B. Issekutz. New York: McGraw-Hill Book Co. 1964.
Itterbeek, H. E. A. van, and L. Delobel: Hyperlipemia familialis idiopathica. T. Gastro.-ent. 7, 52 (1964).
Jahnke, K.: Symposium on pathophvsiological and clinical aspects of lipid metabolism. Heidelberg 1965. G. Schettler (ed.). Stuttgart: Thieme 1966.
Jeanrenatjd, B.: Dynamic aspects of adipose tissue metabolism: A review. Metabolism 10, 535 (1961).
Jepson, E. M., and D. C. O. James: The treatment of hypercholesterolemic xanthomatosis with Atromid. J. Atheroscler. Res. 3, 554 (1963).
Jobst, H., u. G. Schettler: Über die chemische Zusammensetzung der Chylomikronen. 3d Int. Conf. biochem. Probi. Lipids, Brüssels 1956.
Joel, J.: Zur Klinik der Lipämie. Z. Klin. Med. 100, 46 (1924).
Joyner, C. L.: Essential hyperlipemia. Ann. intern. Med. 38, 759 (1953).
Juchems, R., W. Gross, K. Widok, and H. Kaffarnik: Zur Klinik der essentiellen Hyper-lipämie. Münch. med. Wschr. 107, 328 (1965).
Kane, J. P., C. Longcope, F. C. Pavlatos, and G. M. Grodsky: Studies of carbohydrate metabolism in idiopathic hypertriglyceridemia. Metabolism 14, 471 (1965).
Kay, R. E., and C. Entenman: The synthesis of “chylomicron-like” bodies and maintenance of normal blood sugar levels by the isolated, perfused rat liver. J. biol. Chem. 236, 1006 (1961).
Kessler, J. L: Effect of insulin on release of plasma lipolytic activity and clearing of emulified fat intravenously administered to pancreatectomized and alloxanized dogs. J. Lab. clin. Med. 60, 747 (1962).
Kinsell, L. W., G. D. Michaels, G. Walker, S. Splitter, and G. Fukayama: An approach to understanding of the gross hyperlipidemic states. Metabolism 11, 863 (1962).
Kinsell, L. W. and G. Schlierf: Alimentary and nonalimentary hyperglyceridemia. Ann. N. Y. Acad. Sci. 131, 606 (1965).
Kinsell, L. W. and G. Schlierfand R. E. Visintine: Studies of patients with hyperglyceridemia. Amer. J. clin. Nutr. 9, 1 (1961).
Klatskin, G., and M. Gordon: Relationship between relapsing pancreatitis and essential hyperlipemia. Amer. J. Med. 12, 3 (1952).
Knittle, J. L., and E. H. Ahrensjr.: Carbohydrate metabolism in two forms of hyperglyceridemia. J. clin. Invest. 43, 485 (1964).
Knüchel, F.: Das Verhalten der Serumlipide und -lipoproteine unter Verabreichung von Regelan (Äthyl-p-chlorphenoxyisobutyrat). Med. Welt (Beri.) 1964, 2530.
Konttinen, A., and J. Paloheimo: The effects of Atromid on serum lipids, proteins, and some liver function reflecting tests in hypercholesteraemic patients. J. Atheroscler. Res. 3, 525 (1963).
Korn, E. D.: Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J. biol. Chem. 215, 1 (1955).
Koszalka, M. F., and J. J. Levin: Idiopathic hyperlipemia. Ann. intern. Med. 33, 473 (1950).
Kuo, P. T., and D. R. Bassetti: The fat tolerance curves of patients with hyperlipidemia and atherosclerosis. Amer. J. clin. Nutr. 12, 241 (1963).
Kuo, P. T., and D. R. Bassetti: Primary hyperlipidemias and their management. Ann. intern. Med. 59, 495 (1963).
Kuo, P. T., and D. R. Bassetti: Dietary sugar in the production of hyperglyceridemia. Ann. intern. Med. 62,1199 (1965).
Kuo, P. T., and D. R. Bassetti, A. M. Digeorge, and G. G. Carpenter: Lipolytic activity of post-heparin plasma in hyperlipemia and hypolipemia. Circulat. Res. 16, 221 (1965).
Kuo, P. T. and J. C. Carson: Dietary factors and diurnal serum triglyceride levels in man. J. clin. Invest. 38, 1384 (1959).
Kuo, P. T., A. F. Whereat, D. R. Bassett, and E. Staple: Study of the mechanism of hyperlipemia. Serum chylomicron fatty acid patterns of hyperlipemic patients before and after the ingestion of different food fats. Circulation 24, 213 (1961).
Kuo, P. T., A. F. Whereatand O. Horwitz: The effect of lipemia upon coronary and peripheral arterial circulation in patients with essential hyperlipemia. Amer. J. Med. 26, 68 (1959).
Lasch, H. G., W. Kahlke, H. H. Sessneru, K. Schimpf: Zum Wirkungsmechanismus von alimentärem Fett auf die Faktoren der Blutgerinnung, in: „Gefäßwand und Blutplasma“, Symposion Magdeburg 1959, R. Emmrich u. E. Perlick (eds.). Jena: Fischer 1960.
Lees, R. S., and D. S. Fredrickson: Use of paper electrophoresis in the diagnosis and study of hyperglyceridemia. Circulation 30, suppl. III, 20 (1964).
Lees, R. S., and D. S. Fredrickson: Carbohydrate induction of hyperlipemia in normal man. Clin. Res. 13, 327 (1965).
Lees, R. S. and F. T. Hatch: Sharper separation of lipoprotein species by paper electrophoreses in albumin-containing buffer. J. Lab. clin. Med. 61, 518 (1963).
Lepard, C. W.: Lipemia retinalis in the nondiabetic patient. Albrecht v. Graefes Arch. Ophthal. 32, 37 (1944).
Lever, W. F., F. S. M. Herbst, and N. A. Hurley: Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. IV. Effect of prolonged administration of heparin on serum lipids in idiopathic hyperlipemia. Arch. Derm. 71, 150 (1955).
Lever, W. F. and E. Klein: The inhibition of lipemia clearing by hyperlipemio serum. J. invest. Derm. 29, 465 (1957).
Lever, W. F. and E. Klein: Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis: a group of four cases. Arch. Derm. 77, 461 (1958).
Lever, W. F., P. A. J. Smith, and N. A. Hurley: Idiopathic hyperlipemic and primary hypercholesterolemic xanthomatosis. I. Clinical data and analysis of the plasma lipids. J. invest. Derm. 22, 33 (1954).
Levy, B. M.: Idiopathic lipemia. J. Pediat. 29, 376 (1946).
Losowsky, M. S., D. P. Jones, C. S. Davidson, and D. S. Lieber: Studies of alcoholic hyperlipemia and its mechanism. Amer. J. Med. 35, 794 (1963).
Lowgren, E.: Essential hyperlipemia with report of a case including observations before and during pregnancy. Acta med. scand. 142, 71 (1952).
Macdonald, I.: The effects of various dietary carbohydrates on the serum lipids during a five-day regimen. Clin. Sci. 29, 193 (1965).
Macdonald, I. and D. M. Braithwaite: The influence of dietary carbohydrates on the lipid pattern in serum and in adipose tissue. Clin. Sci. 27, 23 (1964).
Malmros, H., B. Swahn, and E. Truedson: Essential hyperlipemia. Acta med. scand. 149, 91 (1954).
Marcus, M.: The pancreas and intermediate fat metabolism; observations on disturbance of the fat metabolism with temporary lipemia in acute pancreatic disease. Fol. clin. orient. (Tel-Aviv) 1, 127 (1937); cit. after Klatskin and Gordon (1952).
Martt, J. M., and W. E. Connor: Idiopathic hyperlipemia associated with coronary atherosclerosis. Arch, intern. Med. 97, 492 (1956).
Matras, A.: Hyperlipämische Xanthomatosen und ihre Behandlung mit Heparin. Arch. klin. exp. Derm. 203, 503 (1956).
Movitt, E. R., G. Gerstl, F. Sherwood, and C. C. Epstein: Essential hyperlipemia. Arch. intern. Med. 87, 79 (1951).
Nestel, P. J.: Relationship between plasma triglycerides and removal of chylomicrons. J.clin. Invest. 43, 943 (1964).
Nestel, P. J., R. J. Havel, and A. Bezman: Extrahepatic removal of chylomicron fatty acids in intact dogs. Fed. Proc. 21, 290 (1962).
Nestel, P. J., R. J. Havel, and A. Bezman: Sites of initial removal of chylomicron triglyceride fatty acids from the blood. J. clin. Invest. 41, 1915 (1962).
New, M. I., T. N. Roberts, E. L. Bierman, and G. G. Reader: The significance of blood lipid alterations in diabetes mellitus. Diabetes 12, 208 (1963).
Nichols, A. V., V. Dobbin, and J. W. Gofman: Influence of dietary factors upon human serum lipoprotein concentrations. Geriatrics 12, 7 (1957).
Nichols, A. V. and L. Smith: Effect of very low-density lipoproteins on lipid transfer in incubated serum. J. Lipid Res. 6, 286 (1965).
Nothman, M. M., and S. Proger: Cephalins in the blood. J. Amer. med. Ass. 179, 40 (1962).
O’Brien, J. R.: Fat ingestion, blood coagulation and atherosclerosis. Amer. J. med. Sci. 234, 373 (1957).
Oliver, M. F.: Reduction of serum-lipid and uric acid levels by an orally active androsterone. Lancet 1962/I, 1321.
Oliver, M. F.: Further observation on the effect of Atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levels. J. Atheroscler. Res. 3, 427 (1963).
Oliver, M. F.: S. D. Roberts, D. Hayes, J. F. Pantridge, M. M. Sttzman, and I. Bersohn: Effect of Atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements. Lancet 1963/I,143.
Opitz, H.: Hochgradige Lipämie unklarer Genese bei einem 12jährigen Knaben. Dtsch. med. Wschr. 61, 88 (1935).
Paronetto, F., C. Wang, and D. Adlersberg: Lipoprotein patterns by starch electrophoresis in idiopathic hyperlipemia and hypercholesteremia. Circulat. Res. 5, 288 (1957).
Pechar, J., H. Vavrinkovà, E. Segovau. E. Kuhn: Über die Fettbindung der Erythrozyten während der postprandialen Lipämie. Folia haemat. (Lpz.) 77, 360 (1960).
Pfleger, L., u. H. Tirschek: Xanthomatose bei idiopathischer Hyperlipämie und Pankrae-titis. Wien. klin. Wschr. 68, 435 (1956).
Potjlsen, H. M.: Familial lipemia. A new form of lipidosis showing increase in neutral fats combined with attacks of acute pancreatitis. Acta med. scand. 138, 413 (1950).
Rändle, P. J., C. N. Hales, P. B. Garland, and E. A. Newsholme: The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963/I, 785.
Ratjsen, A. R., and D. Adlersberg: Idiopathic (hereditary) hyperlipemia and hypercholesterolemia in children. Pediatrics 28, 276 (1961).
Reaven, G. M., J. W. Farqtjhar, L. B. Salans, R. C. Gross, and R. M. Wagner: Carbohydrate-induced lipemia. Clin. Res. 12, 277 (1964).
Reaven, G. M., A. Frank, R. Gross, L. Salans, and J. Farqtjhar: Glucose and insulin metabolism in carbohydrate-induced lipemia. Clin. Res. 13, 332 (1965).
Rodbell, M., D. S. Fredrickson, and K. Ono: Metabolism of chylomicron proteins in the dog. J. biol. Chem. 234, 576 (1959).
Rodbell, M. D. and R. O. Scow: Metabolism of chylomicrons and triglyceride emulsions by perfused rat adipose tissue. Amer. J. Physiol. 208, 106 (1965).
Rohn, R., C. H. Gandek, and M. Bartley: Severe hyperlipemia associated with non-diabetic pregnancy, report of case. Arch, intern. Med. 82, 339 (1948).
Rony, H. R., and T. T. Ching: Studies on fat metabolism. II. The effect of certain hormones on fat transport. Endocrinology 14, 355 (1930).
Rosenman, R.H., and M. Friedman: Effect of acute and chronic administration of heparin on plasma lipids in idiopathic hyperlipemia. Fed. Proc. 13, 121 (1954).
Sanbar, S.S., A.J. Zweifler, and F.J. Conway: Carbohydrate metabolism in essential hyperlipidemia. Circulation 30, suppl. III, 27 (1964).
Schapiro, R. H., R. L. Scheig, G. D. Drtjmmey, J. H. Mendelson, and K. J. Isselbacher: Effect of prolonged ethanol ingestion on the transport and metabolism of lipids in man. New. Engl. J. Med. 272, 610 (1965).
Schettler, G.: Zur Wirkung der lipotropen Substanzen. Klin. Wschr. 1952, 1.
Schettler, G., Lipidosen, in: Handbuch der Inneren Medizin, Bd. VII, Teil 2, p. 609—778. Berlin-Göttingen-Heidelberg: Springer 1955.
Schettler, G. Essentielle Hyperlipämie und Arteriosklerose. In: Arteriosklerose. Ed. G. Schettler. Stuttgart: Thieme 1961.
Schettler, G., M. Eggstein u. H. Jobst: Die essentielle Hyperlipämie. Dtsch. med. Wschr. 83, 1 (1958).
Schettler, G., G. W. Löhru. E. Stein: Die Bedeutung der essentiellen Hyperlipämie und Hyperchole-sterinämie für die Entstehung von Herzinfarkten. Dtsch. med. Wschr. 82, 610 (1957).
Schirren, C: Hyperlipidämische Xanthomatosen. Hautarzt 8, 119 (1957).
Schlierf, G., and L. W. Kinsell: Effects of insulin in hyperglyceridemia. Proc. Soc. exp. Biol. (N. Y.) 120, 272 (1965).
Schön, H., G. Bergu.C. Wiedmann: Untersuchungen über die medikamentöse Beeinflußbarkeit der hyperlipämischen Atherosklerose. Med. u. Ernähr. 4, 233 (1963).
Schrade, W., G. Beckeru.E. Bohle: Das Krankheitsbild der idiopathischen Hyperlipämie. Dtsch. Arch. klin. Med. 201, 344 (1954).
Schrade, W., R. Biegleru. E. Bohle: Die Veränderungen der essentiellen Fettsäuren des Blutes bei verschiedenen Krankheiten, ihre Bewertung und ihre Bedeutung für die Ernährung. Schweiz, med. Wschr. 89,117 (1959).
Schrade, W., E. Bohle, and R. Biegler: Humoral changes in arteriosclerosis. Investigation on lipids, fatty acids, ketone bodies, pyruvic acid, lactic acid, and glucose in the blood. Lancet 1960/II, 1409.
Schtjltze, W. H.: Über großzellige Hyperplasie der Milz bei Hyperlipoidämie. Verh. dtsch. path. Ges. 15, 47 (1912).
Seckfort, H., u. O. Rraun-Falco: Acetalphosphatide bei Xanthomatosen Erkrankungen. Klin. Wschr. 1957, 866.
Shah, S., V. Pomeroy, and L. W. Kinsell: Glyceride and fatty acid response to fat intake in normal and abnormal subjects. Metabolism 12, 887 (1963).
Shapiro, B.: Lipid dynamics in adipose tissue. In: “Progress in the chemistry of fats”; vol. 4. London: Pergamon Press 1957.
Shipp, J. C, and J. F. Munroe: Effects of sulfonurea compounds on hyperlipemia and hypercholesterolemia in patients with minimal impairment of glucose tolerance. Diabetes 11, 69 (1962).
Shore, S. C, and V. Schrire: A possible case of idiopathic hyperlipemia. Clin. Proc. 6, 139 (1947).
Sigstad, H.: A family with mild diabetes mellitus, hyperlipemia and atherosclerosis. Acta med. scand. 177, 465 (1965).
Skipski, V. P., R. F. Peterson, and M. Barclay: Separation of phosphatidyl ethanolamine, phosphatidyl serine, and other phospholipids by thin layer chromatography. J. Lipid Res. 3, 467 (1962).
Smith, E. B.: Lipoprotein patterns in myocardial infarction. Relationship between the components identified by paper electrophoresis and in the ultracentrifuge. Lancet 1957/II, 910.
Soffer, A., and M. Murray: Relationship of essential hyperlipemia to premature atherosclerosis. Circulation 10, 611 (1954).
Strisower, E. H.: The response of hyperlipoproteinemias to Atromid and ethyl chloro-phenoxyisobutyrate. J. Atheroscler. Res. 3, 445 (1963).
Strisower, E. H. and B. Strisower: The separate hypolipoproteinemic effects of dextrothyroxine andethyl chlorophenoxyisobutyrate. J. clin. Endocr. 24, 139 (1964).
Swahn, B.: Studies on blood lipids. Scand. J. clin. Lab. Invest. 5, Suppl. 9 (1953).
Swank, R. L.: Effects of fat on blood viscosity in dogs. Circulat. Res. 4, 579 (1956).
Thannhauser, S. J.: Lipidoses: Diseases of the cellular lipid metabolism. New York: Oxford Press 1950.
Thannhauser, S. J.: Lehrbuch des Stoffwechsels und der Stoffwechselkrankheiten. 2. Aufl. N. Zöllner (ed.). Stuttgart: Thieme 1957.
Thannhauser, S. J.: Lipidoses, Diseases of the Intracellular Lipid Metabolism. 3d edition. New York: Grune and Stratton 1958.
Thannhauser, S. J. and H. Magendantz: The different clinical groups of xanthomatous diseases; a clinical physiological study of 22 cases. Ann. intern. Med. 11, 1662 (1938).
Thannhauser, S. J. and H. Reinstein: Fatty changes in the liver from different causes. Arch. Path. 33, 646 (1942).
Thorp, J. M.: An experimental approach to the problem of disordered lipid metabolism. J. Atheroscler. Res. 3, 351 (1963).
Thorp, J. M., and W. S. Waring: Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate. Nature (Lond.) 194, 948 (1962).
Trenckmann, H.: Idiopathische Hyperlipidämie mit coronaren und peripheren Durchblutungsstörungen. Ärztl. Wschr. 11, 423 (1956).
Troup, S. B., C. F. Reed, G. V. Marinetti, and S. N. Swisher: Thromboplastic factors in platelets and red blood cells: Observations on their chemical nature and function in in vitro coagulation. J. clin. Invest. 39, 342 (1960).
Tyson, J.: A treatise on Bright’s disease and diabetes, p. 267. Philadelphia: Lindsay and Blakiston 1881.
Uzawa, H., G. Schliere, S. Chirman, G. Michaels, P. Wood, and L. W. Kinsell: Hyperglyceridemia resulting from intake of medium chain triglycerides. Amer. J. clin. Nutr. 15,365 (1964).
Vaughan, M.: The metabolism of adipose tissue in vitro. J. Lipid Res. 2, 293 (1961).
Waddell, W. R., R. P. Geyer, N. Hurley, and F.J. Stare: Abnormal carbohydratemetabolism in patients with hypercholesterolemia and hyperlipemia. Metabolism 7, 707 (1958).
Wakil, S. J., and R. Bressler: Fatty acid metabolism and ketone body formation. Metabolism 11, 742 (1962).
Walker, W. J., E. Y. Lawry, D. E. Love, G. V. Mann, S. A. Levine, and F. J. Stare: Effect of weight reduction and caloric balance on serum lipoprotein and cholesterol levels. Amer. J. Med. 14, 654 (1953).
Walton, K. W., P. J. Scott, J. V. Jones, R. F. Fletcher, and T. White-Head: Studies on low-density lipoprotein turnover in relation to Atromid therapy. J. Atheroscler. Res. 3, 396 (1963).
Warren, S., and H. F. Root: Lipoid containing cells in the spleen in diabetes with lipemia. Amer. J. Path. 2, 69 (1926).
Wijnhausen, O. J.: Über Xanthomatose in einem Fall rezidivierender Pankreatitis. Klin. Wschr. 58, 1268 (1921).
Wilkinsonjr., C. F.: Spaced fat feeding: A regime of management for familial hyperlipemia. Ann. intern. Med. 45, 674 (1956).
Wolfson, W. Q., C. Cohn, R. Levine, E. F. Rosenberg, and H. D. Hunt: Liver function and serum protein structure in gout. Ann. intern. Med. 30, 598 (1949).
Wood, P., K. Imaichi, J. Knowles, G. Michaels, and L. W. Kinsell: The lipid composition of human plasma chylomicrons. J. Lipid Res. 5, 225 (1964).
Wood, P., G. Schlierf, and L. W. Kinsell: Plasma free oleic and palmitic acid levels during vigorous exercise. Metabolism 14, 1095 (1965).
Zinn, W. J., and L. A. Schleissner: The effects of dextrothyroxine in diabetes. Calif. Med. 101, 240 (1964).
Zöllner, N.: Angeborene Störungen im Stoffwechsel der Lipoide. Gastroenterologia (Basel) 97, 247 (1962)
Editor information
Rights and permissions
Copyright information
© 1967 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Kinsell, L.W., Schlierf, G., Kahlke, W., Schettler, G. (1967). Essential Hyperlipemia. In: Schettler, G. (eds) Lipids and Lipidoses. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87367-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-87367-6_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-87369-0
Online ISBN: 978-3-642-87367-6
eBook Packages: Springer Book Archive